Home < Research < IWK Researchers' Profiles < Drug Discovery

 

• 2011-2012 IWK Research Annual Report
• About Research at the IWK
• Current Research Studies
• IWK Researchers' Profiles
  • Cancer
  • Children’s Health
  • Drug Discovery
  • Immunology and Infectious Diseases
  • Mental Health
  • Women’s Health
  • Research Profiles A-Z
  • IWK Researchers' Websites
  • Researchers in the News
• Annual Research Reports - Past Years
• Interdisciplinary Research (IDR)
• Research Ethics Board (REB)
• Research Funding Programs
• IWK Research Centres

       Printer Friendly

Drug Discovery

Dalhousie University and IWK Health Centre scientists are working together in two main laboratories at the IWK to discover effective new formulations for treating and preventing common diseases. Researchers in the Canadian Center for Vaccinology are developing novel vaccines to prevent viral and bacterial infections, while researchers in the Cheminformatics and Drug Discovery Laboratory (CDDL) use sophisticated software to design new drugs.

CDDL senior scientists (David Byers, Chris McMaster, Don Weaver), paving the way for the first new class of antibiotics in years
CDDL staff scientists (Chris Barden, Annette Henneberry, Fan Wu), designing, creating and testing new compounds
Chris Richardson, engineering a multi-purpose vaccine against HIV, malaria, avian flu and other lethal pathogens
Jun Wang, in pursuit of the first Chlyamydia vaccine

    Home | Terms of Use/Disclaimer |    © 2006-2009 IWK Health Centre. All rights reserved.